Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Clinical trial NCT02273752 · TERMINATED

Trial details

NCT number: NCT02273752
Sponsor: Emory University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor-positive Breast Cancer Gastrinoma Glucagonoma HER2-negative Breast Cancer Insulinoma Mucositis Oral Complications Pancreatic Polypeptide Tumor Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Recurrent Islet Cell Carcinoma Recurrent Renal Cell Cancer

Start date: 2014-11-01
Primary completion: 2015-12-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.